Symxone S 1000mg/500mg Injection
Marketer
Symlek Healthcare Private Limited
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Symxone S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration must be under a physician's direct guidance. Adherence to the prescribed schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects promptly. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor about all current medications before commencing treatment. Consult your physician if pregnant or breastfeeding. Alcohol should be avoided due to potential additive drowsiness. While generally non-impairing to driving, refrain from driving if experiencing somnolence or vertigo. Adequate rest, balanced nutrition, and hydration will facilitate recovery. Your doctor may order laboratory tests to monitor treatment response.
Uses of Symxone S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Symxone S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Symxone S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Symxone S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Symxone S 1000mg/500mg Injection works:
Symxone S 1000mg/500mg injectable solution unites the actions of Ceftriaxone, a broad-spectrum antibiotic, and Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Symxone S 1000mg/500mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Symxone S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
Administering Symxone S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Symxone S 1000mg/500mg Injection might reduce vigilance, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Symxone S 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Symxone S 1000mg/500mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Symxone S 1000mg/500mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Symxone S 1000mg/500mg Injection :
Should you inadvertently skip a scheduled administration of Symxone S 1000mg/500mg Injection, seek advice from your physician.
Facts to Know About Symxone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently